3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
2
Pain
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Uterine Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Mouth Neoplasms
1
Lung Neoplasms
1
Leiomyoma
1
Inflammation
1
Hyperuricemia
1
Gout
1
Dysmenorrhea
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Arthritis
1
Interventions
Paclitaxel
2
Carboplatin
2
selinexor
1
pazopanib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Pregnancy Tests
1
Naproxen
1
Human Papillomavirus DNA Tests
1
GX-188 vaccine
1
Filgrastim
1
Educational Status
1
Drug Therapy
1
Colposcopy
1
Biopsy
1
Anesthesia, General
1
Acetic Acid
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Uterine Diseases
×
Naproxen
×
Clear all
NCT04145518
2025-12-12
MCUP
Endeavor Health
Phase 4
Completed
183 enrolled